Correction: GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease

• Stephan Sachs,
• Anna Götz,
• Brian Finan,
• Annette Feuchtinger,
• Richard D. DiMarchi,
• Yvonne Döring,
• Christian Weber,
• Matthias H. Tschöp,
• Timo D. Müller,
• Susanna M. Hofmann

Affiliations

Stephan Sachs

Institute for Diabetes and Regeneration, Helmholtz Diabetes Center at Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH)

Anna Götz

Institute for Diabetes and Regeneration, Helmholtz Diabetes Center at Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH)

Brian Finan

Novo Nordisk Research Center Indianapolis

Annette Feuchtinger

Research Unit Analytical Pathology, Helmholtz Center Munich

Richard D. DiMarchi

Department of Chemistry, Indiana University

Yvonne Döring

Department of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, University of Bern

Christian Weber

Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University Munich

Matthias H. Tschöp

Institute for Diabetes and Obesity, Division of Metabolic Diseases, Helmholtz Diabetes Center at Helmholtz Centre Munich

Timo D. Müller

Institute for Diabetes and Obesity, Division of Metabolic Diseases, Helmholtz Diabetes Center at Helmholtz Centre Munich

Susanna M. Hofmann

Institute for Diabetes and Regeneration, Helmholtz Diabetes Center at Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH)